Status:
COMPLETED
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
Lead Sponsor:
Bp Consulting, Inc
Conditions:
Intraocular Pressure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Detailed Description
Open label, single armed, cross over controlled study to evaluate comfort and IOP (Intraocular Pressure) changes of specific NSAIDs post SLT. Patients (n= 25, total 50 eyes) scheduled to undergo bilat...
Eligibility Criteria
Inclusion
- \> 18 years old, either gender or any race.
- Diagnosis of open-angle glaucoma or ocular hypertension requiring laser trabeculoplasty.
- Completion of written and informed consent/authorization prior to any study related procedures.
- Able to follow study protocol and likely to complete study schedule.
Exclusion
- Known sensitivity to NSAIDs.
- History of neovascular or ocular inflammatory disease.
- Current use of topical or systemic anti-inflammatory medications.
- Females of childbearing potential.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00828477
Start Date
January 1 2009
End Date
June 1 2009
Last Update
June 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Coburn-Kleinfeldt Eye Clinic
3340 6 Mile Rd Livonia, Michigan, United States, 48152